Trial Profile
A Phase I Study of weekly ABI-007 in Combination with TS-1 in Patients with Metastatic Breast Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 May 2016
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; TS 01
- Indications Advanced breast cancer
- Focus Adverse reactions
- Sponsors Taiho Pharmaceutical
- 19 May 2016 New trial record